AURIGA PARTNERS
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
AURIGA PARTNERS
Industry:
Venture Capital
Founded:
1998-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apache Euro ReCAPTCHA AJAX Libraries API Google Analytics Classic
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-31 | Vade Secure | Auriga Partners investment in Venture Round - Vade Secure | 28 M EUR |
| 2018-07-06 | Exeliom | Auriga Partners investment in Series A - Exeliom | 7 M EUR |
| 2018-05-16 | Flash Therapeutics | Auriga Partners investment in Private Equity Round - Flash Therapeutics | 3.3 M EUR |
| 2018-04-10 | EnobraQ | Auriga Partners investment in Seed Round - EnobraQ | 2.9 M EUR |
| 2018-01-16 | Pherecydes Pharma | Auriga Partners investment in Series B - Pherecydes Pharma | 8.7 M EUR |
| 2017-10-24 | aveni | Auriga Partners investment in Series B - aveni | 8.9 M EUR |
| 2017-06-13 | Vectalys | Auriga Partners investment in Venture Round - Vectalys | 1.5 M EUR |
| 2017-06-06 | VitaDX | Auriga Partners investment in Seed Round - VitaDX | 1.6 M EUR |
| 2017-03-28 | Nosopharm | Auriga Partners investment in Venture Round - Nosopharm | 2.4 M EUR |
| 2017-02-24 | TxCell | Auriga Partners investment in Post-IPO Equity - TxCell | 11 M EUR |